176
Views
1
CrossRef citations to date
0
Altmetric
Case Series

First Two Case Reports of Becker’s Type Myotonia Congenita in Colombia: Clinical and Genetic Features

, , ORCID Icon &
Pages 473-479 | Published online: 16 Dec 2021

References

  • Sun C, Tranebjaerg L, Torbergsen T, Holmgren G, Van Ghelue M. Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia. Eur J Hum Genet. 2001;9(12):903–909. doi:10.1038/sj.ejhg.5200736
  • Tincheva S, Georgieva B, Todorov T, et al. Myotonia congenita type Becker in Bulgaria: first genetically proven cases and mutation screening of two presumable endemic regions. Neuromuscul Disord. 2016;26(10):675–680. doi:10.1016/j.nmd.2016.08.001
  • Lorenz C, Meyer-Kleine C, Steinmeyer K, Koch MC, Jentsch TJ. Genomic organization of the human muscle chloride channel CIC-1 and analysis of novel mutations leading to Becker-type myotonia. Hum Mol Genet. 1994;3(6):941–946. doi:10.1093/hmg/3.6.941
  • Hudson AJ, Ebers GC, Bulman DE. The skeletal muscle sodium and chloride channel diseases. Brain. 1995;118(Pt 2)):547–563. doi:10.1093/brain/118.2.547
  • Brugnoni R, Kapetis D, Imbrici P, et al. A large cohort of myotonia congenita probands: novel mutations and a high-frequency mutation region in exons 4 and 5 of the CLCN1 gene. J Hum Genet. 2013;58(9):581–587. doi:10.1038/jhg.2013.58
  • Koch M, Harley H, Sarfarazi M, et al. Myotonia congenita (Thomsen’s disease) excluded from the region of the myotonic dystrophy locus on chromosome 19. Hum Genet. 1989;82(2):163–166. doi:10.1007/BF00284051
  • Gutmann L, Phillips LH. Myotonia congenita. Semin Neurol. 1991;11(3):244–248. doi:10.1055/s-2008-1041228
  • de Diego C, Gámez J, Plassart-Schiess E, et al. Novel mutations in the muscle chloride channel CLCN1 gene causing myotonia congenita in Spanish families. J Neurol. 1999;246(9):825–829. doi:10.1007/s004150050462
  • Cassone M, Ferradini V, Longo G, et al. Genotype-phenotype correlation of F484L mutation in three Italian families with Thomsen myotonia. Muscle Nerve. 2017;55(6):E24–5. doi:10.1002/mus.25407
  • Lefter S, Hardiman O, Ryan AM. A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland. Neurology. 2017;88(3):304–313. doi:10.1212/WNL.0000000000003504
  • Huber CD, Kim BY, Lohmueller KE. Population genetic models of GERP scores suggest pervasive turnover of constrained sites across mammalian evolution. PLoS Genet. 2020;16(5):e1008827. doi:10.1371/journal.pgen.1008827
  • Dekker MCJ, Tieleman AA, Igogo OJ, van Duyvenvoorde HA, Howlett WP, Hamel BC. First familial Becker muscular dystrophy in Tanzania: clinical and genetic features. Neuromuscular Disorders. 2019;29(4):317–320. doi:10.1016/j.nmd.2019.01.006
  • Morales F, Cuenca P, Del Valle G, et al. Clinical and molecular diagnosis of a Costa Rican family with autosomal recessive myotonia congenita (Becker disease) carrying a new mutation in the CLCN1 gene. Rev Biol Trop. 2008;56(1):1–11. doi:10.15517/rbt.v56i1.5505
  • Ratbi I, Elalaoui SC, Escudero A, Kriouile Y, Molano J, Sefiani A. Moroccan consanguineous family with Becker myotonia and review. Ann Indian Acad Neurol. 2011;14(4):307–309. doi:10.4103/0972-2327.91963
  • Azevedo HC, Mendonça LI, Salum PN, et al. Congenital myotonia. Report of 7 patients. Arq Neuropsiquiatr. 1996;54(4):595–600. doi:10.1590/S0004-282X1996000400008
  • Dunø M, Myotonia Congenita VJ, Adam MP, et al. GeneReviews® [Internet]. Seattle: University of Washington, Seattle; 1993. Available from http://www.ncbi.nlm.nih.gov/books/NBK1355/. Accessed November 26, 2021.
  • Trujillano D, Bertoli-Avella AM, Kumar Kandaswamy K, et al. Clinical exome sequencing: results from 2819 samples reflecting 1000 families. Eur J Hum Genet. 2017;25(2):176–182. doi:10.1038/ejhg.2016.146
  • Ganapathy A, Mishra A, Soni MR, et al. Multi-gene testing in neurological disorders showed an improved diagnostic yield: data from over 1000 Indian patients. J Neurol. 2019;266(8):1919–1926. doi:10.1007/s00415-019-09358-1
  • Fialho D, Schorge S, Pucovska U, et al. Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. Brain. 2007;130(Pt 12):3265–3274. doi:10.1093/brain/awm248
  • Lee -T-T, Zhang X-D, Chuang -C-C, et al. Myotonia Congenita Mutation Enhances the Degradation of Human CLC-1 Chloride Channels. PLoS One. 2013;8(2):e55930. doi:10.1371/journal.pone.0055930
  • Colding-Jørgensen E, Dunø M, Schwartz M, Vissing J. Decrement of compound muscle action potential is related to mutation type in myotonia congenita. Muscle Nerve. 2003;27(4):449–455. doi:10.1002/mus.10347
  • Ignoul S, Eggermont J. CBS domains: structure, function, and pathology in human proteins. Am J Physiol Cell Physiol. 2005;289(6):C1369–1378. doi:10.1152/ajpcell.00282.2005
  • Kornblum C, Lutterbey GG, Czermin B, et al. Whole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita. Acta Neurol Scand. 2010;121(2):131–135. doi:10.1111/j.1600-0404.2009.01228.x
  • Andersen SP, Sveen M-L, Hansen RS, et al. Creatine kinase response to high-intensity aerobic exercise in adult-onset muscular dystrophy. Muscle Nerve. 2013;48(6):897–901. doi:10.1002/mus.23846
  • Hayashida S, Yanagi F, Tashiro M, Terasaki H. [Anesthetic managements of a patient with congenital myotonia (Becker type)]. Masui. 2004;53(11):1293–1296. Japanese.
  • Stunnenberg BC, LoRusso S, Arnold WD, et al. Guidelines on clinical presentation and management of nondystrophic myotonias. Muscle Nerve. 2020;62(4):430–444. doi:10.1002/mus.26887